Catherine Marshall

Has grant

Assistant Professor

Johns Hopkins University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Catherine Marshall is an Assistant Professor at Johns Hopkins School of Medicine in the United States. Her research focuses on the molecular and clinical implications of germline and somatic interactions in cancer, particularly BRCA-associated cancers and prostate cancer. Recent publications address topics such as DNA repair gene mutations, clonal hematopoiesis, and the therapeutic potentials of various cancer treatments.

Recent Grants

Grant: Close

Cardiorespiratory Fitness

Open Date: 2017-07-01

Close Date: 2018-06-01

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Channing Paller

Johns Hopkins University

UNITED STATES

View details

Siddhartha Yadav

Assistant Professor

Mayo Clinic

UNITED STATES

View details

Lukasz P Gondek

Johns Hopkins University

UNITED STATES

View details

Emmanuel Stylianos Antonarakis

Professor of Medicine, Associate Director for Translation

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Catherine Marshall

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (15)

Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated Cancers

Association of SGLT2 Inhibitor Initiation and PSA Response in Prostate Cancer

Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic Essentiality

Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey‐Holden Prostate Cancer Academy Meeting

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer

Acting on Actionable Mutations in Metastatic Prostate Cancer

Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies

Extreme Responses to a Combination of DNA-Damaging Therapy and Immunotherapy in CDK12-Altered Metastatic Castration-Resistant Prostate Cancer: A Potential Therapeutic Vulnerability

Clinical and genomic features of SPOP‐mutant prostate cancer

Reversing the effects of androgen‐deprivation therapy in men with metastatic castration‐resistant prostate cancer

Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies

Multidisciplinary prevention and management strategies for colorectal cancer and cardiovascular disease

Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

Association between coronary artery calcium and cardiovascular disease as a supporting cause in cancer: The CAC consortium

Coronary Artery Calcium and the Age-Specific Competing Risk of Cardiovascular Versus Cancer Mortality: The Coronary Artery Calcium Consortium

Collaborators (4)

Channing Paller

Siddhartha Yadav

Lukasz P Gondek

Emmanuel Stylianos Antonarakis

Make your next move.